Y. Shiratori

Alcohol consumption appears to protect against non‐alcoholic fatty liver disease

F. Ikeda, H. Taniguchi, Akio Moriya, 2011, Alimentary pharmacology & therapeutics.

Clinical characteristics of fulminant‐type autoimmune hepatitis: an analysis of eleven cases

Y. Miyake, R. Okamoto, R. Terada, 2006, Alimentary pharmacology & therapeutics.

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2006, Alimentary pharmacology & therapeutics.

Base-Line level of tumor markers (AFP and DCP) and their normalization by treatment contribute to the prognosis of patients with hepatocellular carcinomas (HCC)

Shinichiro Nakamura, K. Nouso, M. Kobayashi, 2003 .